What is Oxford Nanopore Technologies Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Oxford Nanopore Technologies Enterprise Value Chart
Competitive Comparison of Oxford Nanopore Technologies's Enterprise Value
For the Biotechnology subindustry, Oxford Nanopore Technologies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford Nanopore Technologies's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Oxford Nanopore Technologies's Enterprise Value falls into.
Oxford Nanopore Technologies Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford Nanopore Technologies (CHIX:ONTl) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Oxford Nanopore Technologies's EV-to-EBIT for today is
Oxford Nanopore Technologies's current Enterprise Value is £1,266.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oxford Nanopore Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was £-151.5 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Oxford Nanopore Technologies's EV-to-EBITDA for today is:
Oxford Nanopore Technologies's current Enterprise Value is £1,266.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oxford Nanopore Technologies's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was £-109.9 Mil.
Oxford Nanopore Technologies's current Enterprise Value is £1,266.0 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oxford Nanopore Technologies's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was £167.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford Nanopore Technologies Enterprise Value Related Terms
Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHIX:ONTL has been successfully added to your 